This invention relates to a kit useful for preventing S. pneumoniae infection in la susceptible individual comprising NDISACC-(4-(4-chlorophenyl)-benzyl)A82846B or teicoplanin, or pharmaceutically acceptable salts, hydrates or solvates thereof, or mixtures thereof and one or more carriers, diluents or excipients, along with an instruction manual and packaging material wherein the amount of NDISACC-(4-(4-chlorophenyl) benzyl)A82846B or teicoplanin is greater than or equal lto 0.5 mg/kg to 10 mg/kg.
| # | Name | Date |
|---|---|---|
| 1 | IN-PCT-2001-1021-KOL-FER-[16-11-2005].pdf | 2005-11-16 |
| 2 | IN-PCT-2001-1021-KOL-LETTER OF PATENT CERTIFICATE-[21-05-2008].pdf | 2008-05-21 |
| 3 | in-pct-2001-1021-kol-granted-translated copy of priority document.pdf | 2011-10-08 |
| 4 | in-pct-2001-1021-kol-granted-specification.pdf | 2011-10-08 |
| 5 | in-pct-2001-1021-kol-granted-reply to examination report.pdf | 2011-10-08 |
| 6 | in-pct-2001-1021-kol-granted-letter patent.pdf | 2011-10-08 |
| 7 | in-pct-2001-1021-kol-granted-gpa.pdf | 2011-10-08 |
| 8 | in-pct-2001-1021-kol-granted-form 5.pdf | 2011-10-08 |
| 9 | in-pct-2001-1021-kol-granted-form 3.pdf | 2011-10-08 |
| 10 | in-pct-2001-1021-kol-granted-form 26.pdf | 2011-10-08 |
| 11 | in-pct-2001-1021-kol-granted-form 2.pdf | 2011-10-08 |
| 12 | in-pct-2001-1021-kol-granted-form 18.pdf | 2011-10-08 |
| 13 | in-pct-2001-1021-kol-granted-form 13.pdf | 2011-10-08 |
| 14 | in-pct-2001-1021-kol-granted-form 1.pdf | 2011-10-08 |
| 15 | in-pct-2001-1021-kol-granted-examination report.pdf | 2011-10-08 |
| 16 | in-pct-2001-1021-kol-granted-drawings.pdf | 2011-10-08 |
| 17 | in-pct-2001-1021-kol-granted-description (complete).pdf | 2011-10-08 |
| 18 | in-pct-2001-1021-kol-granted-correspondence.pdf | 2011-10-08 |
| 19 | in-pct-2001-1021-kol-granted-claims.pdf | 2011-10-08 |
| 20 | in-pct-2001-1021-kol-granted-abstract.pdf | 2011-10-08 |
| 21 | in-pct-2001-1021-kol-21-01-2023-relevent documents.pdf | 2023-01-21 |